ID: h-gwas-ptk2b-endocytosis-axis-5dee99f5
Hypothesis

Tau-trafficking GWAS loci define a druggable PTK2B endocytosis-kinase axis in AD

PTK2B, BIN1, PICALM, and SORL1 form a trafficking and kinase-linked AD risk cluster in the dataset.
🧬 PTK2B/BIN1/PICALM🩺 alzheimers🎯 Composite 59%💱 $0.54▼9.4%proposed
EvidenceStrong (61%)📖 0 cit🗣 1 debates 7 support 1 oppose
⚠ Missing Evidence⚠ Orphaned Senate Quality Gates →

🧪 Overview

PTK2B, BIN1, PICALM, and SORL1 form a trafficking and kinase-linked AD risk cluster in the dataset. The notebook identifies this as a druggable axis because PTK2B is a kinase, BIN1 and PICALM implicate endocytosis, and SORL1 ties the module to APP trafficking. Hypothesis: Pyk2 pathway modulation will normalize tau phosphorylation and endosomal stress in APOE4 or tauopathy human neuronal co-cultures.

🧬 Mechanism

🧬 Curated Mechanism Pathway

Curated pathway from expert analysis

flowchart TD
    A["PTK2B FAK2 Kinase<br/>Postsynaptic Density Component"]
    B["Calcium Influx<br/>NMDAR and Voltage-Gated Channel"]
    C["PTK2B Autophosphorylation<br/>pY402 Kinase Activation"]
    D["PI3K and SRC Coupling<br/>Downstream Effector Cascade"]
    E["PICALM-Mediated Endocytosis<br/>Clathrin AP2 Recruitment"]
    F["BIN1 Membrane Tubulation<br/>Endosomal Tau Routing"]
    G["Tau Seed Propagation<br/>Trans-Synaptic Spread"]
    A --> C
    B --> A
    C --> D
    D --> E
    E --> F
    F --> G
    style A fill:#1a237e,stroke:#4fc3f7,color:#4fc3f7
    style C fill:#7b1fa2,stroke:#ce93d8,color:#ce93d8
    style G fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a

⚖️ Evidence

⚖️ Evidence Matrix7 supports1 contradicts
Supports
PTK2B, BIN1, PICALM, and SORL1 are AD risk loci linked to tau, endocytosis, calcium signaling, and APP trafficking in curated notes.
dataset:ad_genetic_risk_loci
Supports
Druggability ranking favors PTK2B because kinase biology offers a tractable perturbation point across the trafficking module.
notebook:gwas-ad-risk-loci-analysis
Supports
Microglia PTK2B/Pyk2 in the Pathogenesis of Alzheimer's Disease.
Curr Alzheimer Res2023PMID:38321895
Supports
Proteomic analysis identifies HSP90AA1, PTK2B, and ANXA2 in the human entorhinal cortex in Alzheimer's disease: Potential role in synaptic homeostasis and Aβ pathology through microglial and astroglial cells.
Brain Pathol2024PMID:38247340
Supports
Alzheimer risk gene product Pyk2 suppresses tau phosphorylation and phenotypic effects of tauopathy.
Mol Neurodegener2022PMID:35501917
Supports
Pyk2 is a Novel Tau Tyrosine Kinase that is Regulated by the Tyrosine Kinase Fyn.
J Alzheimers Dis2018PMID:29782321
Supports
Spreading of Alzheimer tau seeds is enhanced by aging and template matching with limited impact of amyloid-β.
J Biol Chem2021PMID:34480901
Contradicts
Common GWAS effect sizes are modest and causal direction may differ across neuronal and glial contexts.
notebook:gwas-ad-risk-loci-analysis
📖 Linked Papers

No linked papers recorded for this hypothesis yet.

🏥 Translation

🧬 3D Protein Structure — PTK2B

No curated PDB or AlphaFold mapping for PTK2B yet. Search RCSB →

🧠 GTEx v10 Brain ExpressionJSON

Median TPM across 13 brain regions for PTK2B/BIN1/PICALM from GTEx v10.

Cerebellar Hemisphere232 Cerebellum222 Frontal Cortex BA9119 Cortex108 Nucleus accumbens basal ganglia65.2 Anterior cingulate cortex BA2462.1 Hippocampus59.1 Amygdala35.1 Caudate basal ganglia30.9 Putamen basal ganglia22.2 Spinal cord cervical c-111.8 Hypothalamus10.6 Substantia nigra6.4median TPM (GTEx v10)

💉 Clinical Trials

No clinical trials data linked to this hypothesis yet.

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

🔍 Search ClinVar for PTK2B →

No DepMap CRISPR Chronos data found for PTK2B.

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

🏆 Tournament

🏆 Arenas / Elo

No arena matches recorded yet. Browse Arenas →

📊 Market Indicators

7d Trend
Stable
7d Momentum
▼ 0.3%
Volatility
Low
0.0050
Events (7d)
2
Price History
▼9.4%

💾 Resource Usage

No resource usage or linked notebooks recorded for this hypothesis yet.

🔮 Predictions

🔎 Predictions vs Observations2 predictions · 0 with recorded observations
PredictionPredictedObservedStatusConf
IF PTK2B kinase activity is pharmacologically inhibited (PF-07105691 or genetic knockdown) in APOE4 human iPSC-derived excitatory neurons co-cultured with APOE4 astrocytes, THEN phospho-tau217/181 levSignificant reduction in p-tau217 (≥40% decrease) and normalization of enlarged early endosomes (RAB5+ compartments to <1.2μm mean diameter) measured by high-co— no observation —pending0.72
IF BIN1 or PICALM expression is genetically modulated (BIN1 knockout or PICALM overexpression) in human P301L tau iPSC neurons, THEN PTK2B autophosphorylation (pY402) and downstream phospho-CREB levelBIN1 KO will increase pY402-PTK2B by >60% and p-CREB by >50%; PICALM overexpression will decrease pY402-PTK2B by >40% and p-CREB by >35%, measured by western bl— no observation —pending0.68
🔮 Falsifiable Predictions (2)
pendingconf 72%
IF PTK2B kinase activity is pharmacologically inhibited (PF-07105691 or genetic knockdown) in APOE4 human iPSC-derived excitatory neurons co-cultured with APOE4 astrocytes, THEN phospho-tau217/181 levels will decrease by >40% and endosomal vesicle size will normalize to <1.2μm within 14 days of inte
Predicted outcome: Significant reduction in p-tau217 (≥40% decrease) and normalization of enlarged early endosomes (RAB5+ compartments to <1.2μm mean diameter) measured
Falsification: No significant change (<20%) in phospho-tau levels or persistent endosomal enlargement (>1.5μm) after PTK2B inhibition would falsify the hypothesis that PTK2B modulates tau phosphorylation through end
pendingconf 68%
IF BIN1 or PICALM expression is genetically modulated (BIN1 knockout or PICALM overexpression) in human P301L tau iPSC neurons, THEN PTK2B autophosphorylation (pY402) and downstream phospho-CREB levels will change in opposite directions, confirming a regulatory axis between endocytic proteins and PT
Predicted outcome: BIN1 KO will increase pY402-PTK2B by >60% and p-CREB by >50%; PICALM overexpression will decrease pY402-PTK2B by >40% and p-CREB by >35%, measured by
Falsification: No reciprocal changes in PTK2B phosphorylation following BIN1/PICALM modulation (change <20%) or paradoxical directionality would falsify the existence of a BIN1/PICALM-PTK2B regulatory axis in human
Metadatasource: v1_phase_c_backfill · origin_type: forge_notebook
sourcev1_phase_c_backfill
origin_typeforge_notebook
_schema_version1
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting 0 contradicting 0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.